ArticleCancer immunology, immunotherapy : CII2023

Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model.

Tianyun Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.